Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of end-stage renal disease with limited treatment options. Here the authors discover and characterize a microRNA inhibitor as a potential treatment for ADPKD.
Guardado en:
Autores principales: | Edmund C. Lee, Tania Valencia, Charles Allerson, Annelie Schairer, Andrea Flaten, Matanel Yheskel, Kara Kersjes, Jian Li, Sole Gatto, Mandeep Takhar, Steven Lockton, Adam Pavlicek, Michael Kim, Tiffany Chu, Randy Soriano, Scott Davis, John R. Androsavich, Salma Sarwary, Tate Owen, Julia Kaplan, Kai Liu, Graham Jang, Steven Neben, Philip Bentley, Timothy Wright, Vishal Patel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbe08759988a47b08a2411574e862c56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
por: Sachin Hajarnis, et al.
Publicado: (2017) -
Oligonucleotides
Publicado: (2003) -
An imputation approach for oligonucleotide microarrays.
por: Ming Li, et al.
Publicado: (2013) -
Linkers for oligonucleotide microarray synthesis
por: A.N. Sinyakov, et al.
Publicado: (2021) -
Simultaneous and stoichiometric purification of hundreds of oligonucleotides
por: Alessandro Pinto, et al.
Publicado: (2018)